Starting from 2017, the hepatitis B vaccination has been incorporated into the standard immunisation schedule in the UK, which now includes the 6-in-1 vaccine. Previously, the 5-in-1 vaccine comprised diphtheria, tetanus, pertussis, polio and haemophilus influenza type b. The hepatitis B vaccine is now administered alongside these at 8, 12 and 16 weeks after birth.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at specific intervals. At 12-13 months, the Hib/Men C, MMR, PCV, and Men B vaccines are given. At 3-4 years, the ‘4-in-1 Preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine is also offered to new students up to the age of 25 years at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine, while students going to university or college for the first time should contact their GP to have the vaccine before the start of the academic year.

The Men C vaccine used to be given at 3 months but has now been discontinued as there are almost no cases of Men C disease in babies or young children in the UK. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Understanding Contraindications and Common Reactions to Vaccines

When considering vaccination, it is important to be aware of any contraindications or potential reactions. Acute febrile illness and severe reactions to previous vaccinations are contraindications to any vaccine. Live vaccines should not be given within three weeks of each other, and should not be given to immunosuppressed patients. However, egg allergy is not a contraindication to the MMR vaccine, and mild reactions such as local erythema and induration are common. Similarly, mild symptoms such as rashes or lymphadenopathy are common following live vaccines, and should not deter vaccination. It is important to consult with a healthcare provider to determine the best course of action for each individual case.

Gastro-oesophageal reflux is a common cause of vomiting in infants, with around 40% of babies experiencing some degree of regurgitation. However, certain risk factors such as preterm delivery and neurological disorders can increase the likelihood of developing this condition. Symptoms typically appear before 8 weeks of age and include vomiting or regurgitation, milky vomits after feeds, and excessive crying during feeding. Diagnosis is usually made based on clinical observation.

Management of gastro-oesophageal reflux in infants involves advising parents on proper feeding positions, ensuring the infant is not overfed, and considering a trial of thickened formula or alginate therapy. However, proton pump inhibitors (PPIs) are not recommended as a first-line treatment for isolated symptoms of regurgitation. PPIs may be considered if the infant experiences unexplained feeding difficulties, distressed behavior, or faltering growth. Metoclopramide, a prokinetic agent, should only be used with specialist advice.

Complications of gastro-oesophageal reflux can include distress, failure to thrive, aspiration, frequent otitis media, and dental erosion in older children. If medical treatment is ineffective and severe complications arise, fundoplication may be considered. It is important for healthcare professionals to be aware of the risk factors, symptoms, and management options for gastro-oesophageal reflux in infants.

Syndromes and their Association with Cancer

There are certain syndromes that have been linked to an increased risk of developing certain types of cancer. Down’s syndrome, for example, has been associated with leukaemia, while neurofibromatosis, which is inherited in an autosomal dominant fashion, has been linked to CNS tumours. Other rare syndromes have also been linked to certain cancers.

It is important for primary healthcare professionals to be aware of these associations and to be vigilant for any unexplained symptoms in children or young people with these syndromes. Early detection and treatment can greatly improve outcomes for these patients. Therefore, it is crucial for healthcare professionals to stay informed and up-to-date on the latest research and recommendations regarding these syndromes and their potential links to cancer.

In infant girls, the labia minora may fuse together due to low levels of estrogen. This typically doesn’t cause any symptoms, but in some cases, it may lead to discomfort or pain during urination. Fortunately, labial adhesions usually resolve on their own during puberty and do not have any lasting effects. Treatment is typically unnecessary unless there is pain or discomfort, in which case a brief course of topical estrogen cream may be beneficial.

Labial Adhesions: Causes, Symptoms, and Treatment

Labial adhesions refer to the fusion of the labia minora in the middle, which is commonly observed in girls aged between 3 months and 3 years. This condition can be treated conservatively, and spontaneous resolution usually occurs around puberty. It is important to note that labial adhesions are different from an imperforate hymen.

Symptoms of labial adhesions include problems with urination, such as pooling in the vagina. Upon examination, thin semitranslucent adhesions covering the vaginal opening between the labia minora may be seen, which can sometimes cover the vaginal opening completely.

Conservative management is usually appropriate for most cases of labial adhesions. However, if there are associated problems such as recurrent urinary tract infections, oestrogen cream may be tried. If this fails, surgical intervention may be necessary.

In summary, labial adhesions are a common condition in young girls that can cause problems with urination. While conservative management is usually effective, medical intervention may be necessary in some cases.

Understanding Infantile Spasms

Infantile spasms, also known as West syndrome, is a form of epilepsy that typically occurs in infants between 4 to 8 months old, with a higher incidence in male infants. This condition is often associated with an underlying serious medical condition and has a poor prognosis.

The characteristic feature of infantile spasms is the salaam attack, which involves the flexion of the head, trunk, and arms followed by the extension of the arms. These attacks last only 1-2 seconds but can be repeated up to 50 times. Infants with this condition may also experience progressive mental handicap.

To diagnose infantile spasms, an EEG is typically performed, which may show hypsarrhythmia in two-thirds of infants. A CT scan may also be done, which can reveal diffuse or localized brain disease in 70% of cases, such as tuberous sclerosis.

Unfortunately, infantile spasms carry a poor prognosis. However, there are treatment options available. Vigabatrin is now considered first-line therapy, and ACTH is also used.

Desmopressin is a viable option for managing enuresis in the short term, particularly in children aged 7 and above. However, its effectiveness in younger children is not well-established. It is advisable to commence treatment a week before a school trip to assess its efficacy. Simply limiting fluid intake is not recommended. Karim should be offered desmopressin as a treatment option, along with reassurance. Duloxetine is not suitable for this condition. While an enuresis alarm is a viable long-term solution, it is not practical to try it out during a school trip.

Managing Nocturnal Enuresis in Children

Nocturnal enuresis, also known as bedwetting, is a common condition in children. It is defined as the involuntary discharge of urine during sleep in children aged 5 years or older who have not yet achieved continence. There are two types of nocturnal enuresis: primary and secondary. Primary enuresis occurs when a child has never achieved continence, while secondary enuresis occurs when a child has been dry for at least 6 months before.

When managing nocturnal enuresis, it is important to look for possible underlying causes or triggers such as constipation, diabetes mellitus, or recent onset urinary tract infections. General advice includes monitoring fluid intake and encouraging regular toileting patterns, such as emptying the bladder before sleep. Lifting and waking techniques and reward systems, such as star charts, can also be effective.

The first-line treatment for nocturnal enuresis is an enuresis alarm, which has a high success rate. These alarms have sensor pads that detect wetness and wake the child up when they start to wet the bed. If an enuresis alarm is not effective or not acceptable to the family, desmopressin can be used for short-term control, such as for sleepovers. It is important to note that reward systems should be given for agreed behavior rather than dry nights, such as using the toilet to pass urine before sleep. By following these management strategies, children with nocturnal enuresis can achieve continence and improve their quality of life.

The NICE paediatric traffic light system identifies a respiratory rate of over 60 per minute as a red flag, regardless of age. Other symptoms that are considered amber or red flags include decreased urine output, dry mucous membranes, and a heart rate of over 150 beats per minute in 12-24-month-olds. A fever of over 39ºC is not an amber or red symptom, but it is considered an amber symptom in 3-6-month-olds and a red flag in children under 3 months.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013 to provide a ‘traffic light’ system for assessing the risk of febrile illness in children under 5 years old. The guidelines recommend recording the child’s temperature, heart rate, respiratory rate, and capillary refill time, as well as looking for signs of dehydration. Measuring temperature should be done with an electronic thermometer in the axilla for children under 4 weeks or with an electronic/chemical dot thermometer in the axilla or an infra-red tympanic thermometer. The risk stratification table categorizes children as green (low risk), amber (intermediate risk), or red (high risk) based on their symptoms. Management recommendations vary depending on the risk level, with green children managed at home, amber children provided with a safety net or referred to a specialist, and red children urgently referred to a specialist. The guidelines also advise against prescribing oral antibiotics without an apparent source of fever and note that a chest x-ray is not necessary if a child with suspected pneumonia is not being referred to the hospital.

Newborn Hearing Screening in the UK

The newborn hearing screening is a routine test that takes place shortly after birth in hospitals across the UK. If a clear response is found in both ears, no further action is needed. However, if there is not a clear response in both ears, further testing may be required. The screening programmes differ between England, Scotland, and Wales. In Wales, a clear response in one ear doesn’t automatically prompt further investigation, but parents are given the option to have another hearing screening test or wait until their baby is nine months old for a hearing test. In England and Scotland, further testing is automatically arranged if there is a clear response in only one ear.

For newborns with ‘not clear’ responses bilaterally, further testing is necessary to determine if there is a significant hearing deficit. It is important to note that early detection and intervention for hearing loss can greatly improve a child’s language and communication skills. The UK National Screening Committee provides more information on newborn hearing screening across the UK.

Paediatric vital signs refer to the normal range of heart rate and respiratory rate for children of different ages. These vital signs are important indicators of a child’s overall health and can help healthcare professionals identify any potential issues. The table below outlines the age-appropriate ranges for heart rate and respiratory rate. Children under the age of one typically have a higher heart rate and respiratory rate, while older children have lower rates. It is important for healthcare professionals to monitor these vital signs regularly to ensure that children are healthy and developing properly.

Age Heart rate Respiratory rate
< 1 110 - 160 30 - 40
1 – 2 100 – 150 25 – 35
2 – 5 90 – 140 25 – 30
5 – 12 80 – 120 20 – 25
> 12 60 – 100 15 – 20

Understanding Rickets: Causes and Symptoms

Rickets is a condition that affects bone development in children, caused by a severe deficiency of vitamin D. This vitamin is essential for bone mineralization, and without it, bones become soft and weak, leading to deformities and impaired growth. In adults, the condition is known as osteomalacia and can cause bone pain and tenderness.

The most common cause of rickets is a dietary deficiency of vitamin D, which can be compounded by inadequate exposure to sunlight. Other risk factors include having dark skin and following a vegetarian diet. Oily fish and cod liver oil are the best food sources of vitamin D.

Hyperparathyroidism, cystic fibrosis, nephrotic syndrome, and juvenile idiopathic arthritis are all potential causes of bone abnormalities, but they are not typically associated with rickets. Hyperparathyroidism and nephrotic syndrome can cause bone-related issues, but they are not commonly associated with rickets. Cystic fibrosis and other malabsorption diseases can lead to vitamin D deficiency, but they typically present with other symptoms such as recurrent chest infections. Juvenile idiopathic arthritis causes joint pain and swelling, rather than bony deformities.

In summary, rickets is a condition caused by a severe deficiency of vitamin D, which can lead to bone deformities and impaired growth in children. It is important to ensure adequate vitamin D intake through diet and sunlight exposure to prevent this condition.

If a patient with scarlet fever has a penicillin allergy and doesn’t require hospitalization, they should be treated with oral azithromycin for 5 days, as per the current NICE CKS guidance. For patients without a penicillin allergy, a 10-day course of oral phenoxymethylpenicillin (penicillin V) or amoxicillin (if there are difficulties swallowing tablets) is recommended. Scarlet fever is a notifiable disease, and healthcare professionals should complete a notification form and send it to Public Health England (PHE) within 3 days if there is a suspicion of the disease.

Scarlet fever is a condition caused by erythrogenic toxins produced by Group A haemolytic streptococci, usually Streptococcus pyogenes. It is more common in children aged 2-6 years, with the highest incidence at 4 years. The disease is spread through respiratory droplets or direct contact with nose and throat discharges. The incubation period is 2-4 days, and symptoms include fever, malaise, headache, sore throat, ‘strawberry’ tongue, and a rash that appears first on the torso and spares the palms and soles. Scarlet fever is usually a mild illness, but it may be complicated by otitis media, rheumatic fever, acute glomerulonephritis, or rare invasive complications.

To diagnose scarlet fever, a throat swab is usually taken, but antibiotic treatment should be started immediately, rather than waiting for the results. Management involves oral penicillin V for ten days, while patients with a penicillin allergy should be given azithromycin. Children can return to school 24 hours after starting antibiotics, and scarlet fever is a notifiable disease. Desquamation occurs later in the course of the illness, particularly around the fingers and toes. The rash is often described as having a rough ‘sandpaper’ texture, and children often have a flushed appearance with circumoral pallor. Invasive complications such as bacteraemia, meningitis, and necrotizing fasciitis are rare but may present acutely with life-threatening illness.

The child has temporary lactose intolerance due to a deficiency in enzymes caused by viral gastroenteritis. It is recommended to avoid lactose-containing foods for two weeks to one month, after which lactose can be reintroduced to the diet. If symptoms recur, a specialist should be consulted. Antibiotics such as metronidazole and ciprofloxacin are not effective in treating this condition. Symptoms should resolve spontaneously with a lactose-free diet. Primary lactase deficiency is a common genetic condition that can be managed by determining the amount of lactose that can be tolerated and taking it in divided portions throughout the day.

When assessing a premature baby’s developmental milestones, their corrected age is used instead of their actual age. The corrected age is calculated by subtracting the number of weeks the baby was born early from 40 weeks. A responsive smile is typically expected to appear between 6 to 8 weeks of age. However, for a premature baby born at 32 weeks gestation, their corrected age would be 14 to 16 weeks when assessing their ability to show a responsive smile. The corrected age is used as a reference until the child reaches the age of 2.

Developmental Milestones in Social Behaviour, Feeding, Dressing, and Play

Developmental milestones are important markers in a child’s growth and development. In terms of social behaviour and play, there are several milestones that parents and caregivers can look out for. At six weeks, a baby may start to smile, which develops into laughter by three months. At six months, they become less shy, but by nine months, they may exhibit shyness. Additionally, babies at this age tend to put everything in their mouths.

In terms of feeding, a six-month-old may start to put their hand on the bottle while being fed. By 12-15 months, they can drink from a cup and use a spoon, which develops over a three-month period. At two years, they become competent with a spoon and don’t spill with a cup, and by three years, they can use a spoon and fork. Finally, at five years, they can use a knife and fork.

When it comes to dressing, a child may start to help with getting dressed and undressed at 12-15 months. By 18 months, they can take off shoes and hats but may not be able to replace them. At two years, they can put on hats and shoes, and by four years, they can dress and undress independently, except for laces and buttons.

Lastly, in terms of play, a nine-month-old may start to play peek-a-boo and wave bye-bye. By 12 months, they may play pat-a-cake, and at 18 months, they can play contentedly alone. At two years, they may play near others but not necessarily with them, and by four years, they can play with other children. These milestones can help parents and caregivers track a child’s development and ensure they are meeting age-appropriate goals.

Patellofemoral pain syndrome is a common knee condition that affects a large number of individuals. It typically develops slowly and starts off as mild and sporadic, but can eventually become severe and persistent. The pain is alleviated by taking a break and exacerbated by activities like kneeling, running, or jumping.

Knee Problems in Children and Young Adults

Knee problems are common in children and young adults, and can be caused by a variety of conditions. Chondromalacia patellae is a condition that affects teenage girls and is characterized by softening of the cartilage of the patella. This can cause anterior knee pain when walking up and down stairs or rising from prolonged sitting. However, it usually responds well to physiotherapy.

Osgood-Schlatter disease, also known as tibial apophysitis, is often seen in sporty teenagers. It causes pain, tenderness, and swelling over the tibial tubercle. Osteochondritis dissecans can cause pain after exercise, as well as intermittent swelling and locking. Patellar subluxation can cause medial knee pain due to lateral subluxation of the patella, and the knee may give way. Patellar tendonitis is more common in athletic teenage boys and causes chronic anterior knee pain that worsens after running. It is tender below the patella on examination.

It is important to note that referred pain may come from hip problems such as slipped upper femoral epiphysis. Understanding the key features of these common knee problems can help with early diagnosis and appropriate treatment.

Young women presenting with midfoot pain on walking should consider Freiberg’s disease as a possible cause. This condition occurs when the blood supply to the metatarsal head is interrupted, leading to infarction and flattening of the affected area. It is most commonly seen in adolescents, particularly tall, athletic females, whose bones may grow faster than blood vessels can keep up with. Symptoms include pain, swelling, and stiffness, which can be managed with conservative measures, although improvement may take up to a year. Other conditions that may cause similar symptoms include Morton’s neuroma, complex regional pain syndrome, and sesamoiditis, but each has its own unique presentation and risk factors.

Understanding Freiberg Disease

Freiberg disease, also known as metatarsal avascular necrosis, is a condition that occurs when the blood supply to the metatarsal head is disrupted, leading to infarction and flattening of the affected area. This condition is most commonly observed in adolescents, particularly tall, athletic females, as their bones may grow faster than blood vessels can keep up with. The second metatarsal is the most commonly affected area.

The symptoms of Freiberg’s disease include pain, swelling, and stiffness, which can be managed through conservative measures such as activity limitation, analgesia, and orthotic devices like walking casts or boots. While operative management is rarely necessary, it is important to inform patients that improvement can be gradual and may take up to a year.

Overall, understanding Freiberg disease is crucial for individuals who may be at risk, as early detection and management can help prevent further complications and improve overall outcomes.

In March 2018, NICE released new guidelines for the recognition and management of Attention Deficit Hyperactivity Disorder (ADHD). This condition can have a significant impact on a child’s life and can continue into adulthood, making accurate diagnosis and treatment crucial. ADHD is defined by DSM-V as a persistent condition that includes features of inattention and/or hyperactivity/impulsivity, with an element of developmental delay. The threshold for diagnosis is six features for children up to 16 years old and five features for those aged 17 or over. ADHD has a prevalence of 2.4% in the UK, with a possible genetic component and a higher incidence in boys than girls.

NICE recommends a holistic approach to treating ADHD that is not solely reliant on medication. After presentation, a ten-week observation period should follow to determine if symptoms change or resolve. If symptoms persist, referral to secondary care is necessary, usually to a paediatrician with a special interest in behavioural disorders or to the local Child and Adolescent Mental Health Service (CAMHS). A tailored plan of action should be developed, taking into account the patient’s needs and wants and how their condition affects their lives.

Drug therapy should be considered a last resort and is only available to those aged 5 years or older. For patients with mild/moderate symptoms, parents attending education and training programmes can be beneficial. For those who fail to respond or have severe symptoms, pharmacotherapy can be considered. Methylphenidate is the first-line treatment for children and should be given on a six-week trial basis. Lisdexamfetamine can be used if there is an inadequate response, and dexamfetamine can be started in those who have benefited from lisdexamfetamine but cannot tolerate its side effects. In adults, methylphenidate or lisdexamfetamine are first-line options, with switching between drugs if no benefit is seen after a trial of the other.

All of these drugs have the potential to be cardiotoxic, so a baseline ECG should be performed before starting treatment. Referral to a cardiologist is necessary if there is any significant past medical history or family history, or any doubt or ambiguity. A thorough history and clinical examination are essential for accurate diagnosis, given the overlap of ADHD with many other psychiatric and physical conditions.

Rickets and its Risk Factors in Dark-Skinned Populations

Rickets is a condition that affects bone development in children, and dark skin is a risk factor for this condition in certain populations. In the United Kingdom, South Asian, African Caribbean, and Middle Eastern descent populations are particularly at risk. A study conducted in Bristol found that most cases of rickets were among Somali patients. The study identified 31 children with vitamin D deficiency, seven of whom had bone or limb pain, seven had bow legs or swollen joints, one had convulsions, and one had respiratory difficulty. Twelve children were asymptomatic and diagnosed through screening after a family member was found to have vitamin D deficiency. Fibromyalgia, infantile tibia vara, juvenile chronic arthritis, and physiological bow leg deformity are not related to rickets. It is important to identify and address risk factors for rickets in order to prevent and treat this condition.

Management of Unilateral Otitis Media in Primary Care

This child doesn’t exhibit any life-threatening symptoms or signs of serious illness. Based on the NICE ‘traffic light’ system, there are no ‘red’ or ‘amber’ indicators. The most probable diagnosis is unilateral otitis media, which can be safely managed in primary care. Parents should be advised to administer Calpol and/or Nurofen for pain relief and encourage oral fluids. The average duration of acute otitis media is four days.

Immediate antibiotics are only necessary for children with bilateral acute otitis media under the age of two, otorrhoea, systemic illness, symptoms and signs of serious illness and/or complications, or high risk of complications due to pre-existing comorbidity. Despite national guidelines, a large primary care study has shown that antibiotic prescribing remains high. Antibiotic prescriptions for otitis media have increased from 77% in 1995 to 85% in 2011. Therefore, it is crucial to educate patients on the natural duration of common infections and the potential harm of inappropriate antibiotic use.

In most cases, labial adhesion can be resolved through conservative methods. However, if the individual experiences symptoms such as pain, difficulty urinating, or dribbling, it is recommended to apply oestrogen cream for a period of 6 weeks until the membrane dissolves. Following this, an emollient should be applied for a duration of 2 months.

Labial Adhesions: Causes, Symptoms, and Treatment

Labial adhesions refer to the fusion of the labia minora in the middle, which is commonly observed in girls aged between 3 months and 3 years. This condition can be treated conservatively, and spontaneous resolution usually occurs around puberty. It is important to note that labial adhesions are different from an imperforate hymen.

Symptoms of labial adhesions include problems with urination, such as pooling in the vagina. Upon examination, thin semitranslucent adhesions covering the vaginal opening between the labia minora may be seen, which can sometimes cover the vaginal opening completely.

Conservative management is usually appropriate for most cases of labial adhesions. However, if there are associated problems such as recurrent urinary tract infections, oestrogen cream may be tried. If this fails, surgical intervention may be necessary.

In summary, labial adhesions are a common condition in young girls that can cause problems with urination. While conservative management is usually effective, medical intervention may be necessary in some cases.

According to the Green Book, it is recommended to have a 3-month gap between doses for optimal response rate. However, if the child is over 10 years old, a 1-month gap is sufficient. In case of an emergency, such as an outbreak at the child’s school, younger children can have a shorter gap of 1 month.

MMR Vaccine: Information on Administration, Contraindications, and Adverse Effects

The Measles, Mumps and Rubella (MMR) vaccine is given to children in the UK twice before they enter primary school. The first dose is administered at 12-15 months, while the second dose is given at 3-4 years old. This vaccine is part of the routine immunisation schedule for children.

However, there are certain contraindications to the MMR vaccine. Children with severe immunosuppression, allergies to neomycin, or those who have received another live vaccine by injection within four weeks should not receive the MMR vaccine. Pregnant women should also avoid getting vaccinated for at least one month following the MMR vaccine. Additionally, if a child has undergone immunoglobulin therapy within the past three months, there may be no immune response to the measles vaccine if antibodies are present.

While the MMR vaccine is generally safe, some adverse effects may occur. After the first dose of the vaccine, children may experience malaise, fever, and rash. These symptoms typically occur after 5-10 days and last for around 2-3 days. It is important to note that the benefits of the MMR vaccine far outweigh the risks, as it protects against serious and potentially life-threatening diseases.

Understanding Kawasaki Disease

Kawasaki disease is a rare type of vasculitis that primarily affects children. It is important to identify this disease early on as it can lead to serious complications such as coronary artery aneurysms. The disease is characterized by a high-grade fever that lasts for more than five days, which is resistant to antipyretics. Other features include conjunctival injection, bright red, cracked lips, strawberry tongue, cervical lymphadenopathy, and red palms and soles that later peel.

Diagnosis of Kawasaki disease is based on clinical presentation as there is no specific diagnostic test available. Management of the disease involves high-dose aspirin, which is one of the few indications for aspirin use in children. Intravenous immunoglobulin is also used as a treatment option. Echocardiogram is the initial screening test for coronary artery aneurysms instead of angiography.

Complications of Kawasaki disease include coronary artery aneurysm, which can be life-threatening. Early recognition and treatment of Kawasaki disease can prevent serious complications and improve outcomes for affected children.

Parents should be informed that if their child experiences a febrile convulsion lasting longer than 5 minutes, they should immediately call for an ambulance. While some children may have recurrent febrile convulsions, simple ones typically last up to 15 minutes and result in complete recovery within an hour. In these cases, parents can manage their child at home with clear guidance on when to seek medical help and the use of medications like buccal midazolam or rectal diazepam. However, any febrile convulsion lasting longer than 5 minutes requires immediate medical attention, and if a second convulsion occurs within 30 minutes of the first, parents should also call for an ambulance.

Febrile convulsions are seizures that occur in otherwise healthy children when they have a fever. They are most common in children between the ages of 6 months and 5 years, affecting around 3% of children. Febrile convulsions usually occur at the onset of a viral infection when the child’s temperature rises rapidly. The seizures are typically brief, lasting less than 5 minutes, and are usually tonic-clonic in nature.

There are three types of febrile convulsions: simple, complex, and febrile status epilepticus. Simple febrile convulsions last less than 15 minutes and are generalised seizures. Complex febrile convulsions last between 15 and 30 minutes and may be focal seizures. Febrile status epilepticus lasts for more than 30 minutes. Children who have had their first seizure or any features of a complex seizure should be admitted to paediatrics.

Following a seizure, parents should be advised to call an ambulance if the seizure lasts longer than 5 minutes. Regular antipyretics have not been shown to reduce the chance of a febrile seizure occurring. If recurrent febrile convulsions occur, benzodiazepine rescue medication may be considered, but this should only be started on the advice of a specialist, such as a paediatrician. Rectal diazepam or buccal midazolam may be used.

The overall risk of further febrile convulsions is 1 in 3, but this varies depending on risk factors for further seizure. These risk factors include age of onset under 18 months, fever below 39ºC, shorter duration of fever before the seizure, and a family history of febrile convulsions. Children with no risk factors have a 2.5% risk of developing epilepsy, while those with all three risk factors have a much higher risk of developing epilepsy, up to 50%.

Polio Vaccination and Neurological Conditions

The Department of Health’s ‘Green Book’ provides guidelines for polio vaccination and neurological conditions. According to the book, stable pre-existing neurological conditions such as spina bifida and congenital brain abnormalities do not prevent polio vaccination. However, if a child has an unstable or deteriorating neurological condition, vaccination should be deferred, and the child should be referred to a specialist for further assessment and advice. This includes children with uncontrolled epilepsy.

It is important to note that a family history of seizures or epilepsy doesn’t prevent immunization. However, if there is a personal or family history of febrile seizures, there is an increased risk of these occurring after any fever, including post-immunization. In such cases, immunization should proceed as recommended, with advice on the prevention and management of fever beforehand.

Indications for Paediatric Circumcision

There are several indications for paediatric circumcision, with the most common being pathological phimosis. This occurs when scarring of the opening of the foreskin makes it non-retractable, which is rare before the age of 5 years. In such cases, circumcision is the only absolute indication.

Recurrent episodes of balanoposthitis, or infection beneath the foreskin, can also be an indication for circumcision. While this is not a common occurrence, it can be troublesome and may require surgical intervention.

In rare cases, paediatric circumcisions may be required for other conditions. However, these are not as common as pathological phimosis or balanoposthitis. It is important to consult with a healthcare provider to determine if circumcision is necessary for your child.

Treatment options for deliberate self-harming in adolescents

SSRIs and tricyclics are not recommended for the treatment of deliberate self-harming in adolescents. The Committee on Safety of Medicines (CSM) advises that the balance of risks and benefits for the use of SSRIs in individuals under 18 years is unfavorable. Fluoxetine has shown some benefit, but there are concerns regarding an increased risk of self-harm and suicidal thoughts. Therefore, counselling with family therapy is the preferred option for treating deliberate self-harming in adolescents. It is important to consider the potential risks and benefits of any treatment option and to work closely with healthcare professionals to determine the best course of action for each individual case. By prioritizing the mental health and well-being of adolescents, we can help prevent and manage deliberate self-harming behaviors.

The MenB vaccine is administered at 2, 4, and 12-13 months and has been incorporated into the routine vaccination schedule in the UK, making it the first country to do so. The vaccine replaces the MenC vaccine, which was discontinued in 2016. In addition to infants, individuals with certain health conditions, such as asplenia or splenic dysfunction, sickle cell anaemia, coeliac disease, and complement disorders, are also recommended to receive the MenB vaccine. It is important to note that the vaccine doesn’t contain live bacteria and therefore cannot cause meningococcal disease.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at specific intervals. At 12-13 months, the Hib/Men C, MMR, PCV, and Men B vaccines are given. At 3-4 years, the ‘4-in-1 Preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine is also offered to new students up to the age of 25 years at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine, while students going to university or college for the first time should contact their GP to have the vaccine before the start of the academic year.

The Men C vaccine used to be given at 3 months but has now been discontinued as there are almost no cases of Men C disease in babies or young children in the UK. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

If alginates/thickened feeds fail to alleviate symptoms in infants with GORD and they exhibit feeding difficulties, distressed behavior, or faltering growth, a trial of PPI is recommended by NICE. However, metoclopramide should not be used without specialist advice due to the risk of side-effects like dystonia. Restarting breastfeeding is not practical once it has stopped, and there is no evidence to suggest that it would improve symptoms. While cow’s milk protein intolerance should be considered as a differential diagnosis, there is currently no indication of this diagnosis. Additionally, it is not advisable to stop milk feeds for such a young baby.

Gastro-oesophageal reflux is a common cause of vomiting in infants, with around 40% of babies experiencing some degree of regurgitation. However, certain risk factors such as preterm delivery and neurological disorders can increase the likelihood of developing this condition. Symptoms typically appear before 8 weeks of age and include vomiting or regurgitation, milky vomits after feeds, and excessive crying during feeding. Diagnosis is usually made based on clinical observation.

Management of gastro-oesophageal reflux in infants involves advising parents on proper feeding positions, ensuring the infant is not overfed, and considering a trial of thickened formula or alginate therapy. However, proton pump inhibitors (PPIs) are not recommended as a first-line treatment for isolated symptoms of regurgitation. PPIs may be considered if the infant experiences unexplained feeding difficulties, distressed behavior, or faltering growth. Metoclopramide, a prokinetic agent, should only be used with specialist advice.

Complications of gastro-oesophageal reflux can include distress, failure to thrive, aspiration, frequent otitis media, and dental erosion in older children. If medical treatment is ineffective and severe complications arise, fundoplication may be considered. It is important for healthcare professionals to be aware of the risk factors, symptoms, and management options for gastro-oesophageal reflux in infants.

Managing Asthma in Children: NICE Guidelines

The National Institute for Health and Care Excellence (NICE) released guidelines in 2017 for the management of asthma in children aged 5-16. These guidelines follow a stepwise approach, with treatment options based on the severity of the child’s symptoms. For newly-diagnosed asthma, short-acting beta agonists (SABA) are recommended. If symptoms persist or worsen, a combination of SABA and paediatric low-dose inhaled corticosteroids (ICS) may be used. Leukotriene receptor antagonists (LTRA) and long-acting beta agonists (LABA) may also be added to the treatment plan.

For children under 5 years old, clinical judgement plays a greater role in diagnosis and treatment. The stepwise approach for this age group includes an 8-week trial of paediatric moderate-dose ICS for newly-diagnosed asthma or uncontrolled symptoms. If symptoms persist, a combination of SABA and paediatric low-dose ICS with LTRA may be used. If symptoms still persist, referral to a paediatric asthma specialist is recommended.

It is important to note that NICE doesn’t recommend changing treatment for patients with well-controlled asthma simply to adhere to the latest guidelines. Additionally, maintenance and reliever therapy (MART) may be used for combined ICS and LABA treatment, but only for LABAs with a fast-acting component. The definitions for low, moderate, and high-dose ICS have also changed, with different definitions for children and adults.

Soya milk may not be a suitable alternative for infants with cow’s milk protein allergy as many of them are also intolerant to it. Amino acid-based formula is the recommended management for severe cases or when extensive hydrolysed formula milk is ineffective.

Breastfeeding is encouraged if the mother eliminates cows milk proteins from her diet, but it may not be practical if she cannot produce enough milk for the child. For infants with mild to moderate cows milk protein allergy who are formula-fed, extensive hydrolysed milk formula is the first-line management.

Gastro-oesophageal reflux (GORD) may be managed with omeprazole or ranitidine, but only after a 1-2 week trial of alginate therapy. However, if the infant presents with persistent diarrhoea, cow’s milk protein allergy is a more likely diagnosis than GORD.

Cow’s milk protein intolerance/allergy (CMPI/CMPA) is a condition that affects approximately 3-6% of children and typically presents in formula-fed infants within the first 3 months of life. However, it can also occur in exclusively breastfed infants, although this is rare. Both immediate (IgE mediated) and delayed (non-IgE mediated) reactions can occur, with CMPA usually used to describe immediate reactions and CMPI for mild-moderate delayed reactions. Symptoms of CMPI/CMPA include regurgitation and vomiting, diarrhea, urticaria, atopic eczema, colic symptoms such as irritability and crying, wheezing, chronic cough, and rarely, angioedema and anaphylaxis.

Diagnosis of CMPI/CMPA is often based on clinical presentation, such as improvement with cow’s milk protein elimination. However, investigations such as skin prick/patch testing and total IgE and specific IgE (RAST) for cow’s milk protein may also be performed. If symptoms are severe, such as failure to thrive, referral to a pediatrician is necessary.

Management of CMPI/CMPA depends on whether the child is formula-fed or breastfed. For formula-fed infants with mild-moderate symptoms, extensive hydrolyzed formula (eHF) milk is the first-line replacement formula, while amino acid-based formula (AAF) is used for infants with severe CMPA or if there is no response to eHF. Around 10% of infants with CMPI/CMPA are also intolerant to soy milk. For breastfed infants, mothers should continue breastfeeding while eliminating cow’s milk protein from their diet. Calcium supplements may be prescribed to prevent deficiency while excluding dairy from the diet. When breastfeeding stops, eHF milk should be used until the child is at least 12 months old and for at least 6 months.

The prognosis for CMPI/CMPA is generally good, with most children eventually becoming milk tolerant. In children with IgE-mediated intolerance, around 55% will be milk tolerant by the age of 5 years, while in children with non-IgE mediated intolerance, most will be milk tolerant by the age of 3 years. However, a challenge is often performed in a hospital setting as anaphylaxis can occur.